WAT
Waters Corporation
Set alert
- YTD
- +21.82%
- 1 year
- +34.94%
- Open
- 479.04
- Prev close
- 480.07
- Mkt cap
- 45.43B
- Vol
- 1.34M
- Avg vol
- 803.65K
- EPS
- 3.95
- P/E
- 117.14
- Div yield
- 0.00%
More statistics
- Low
- 458.85
- High
- 479.60
- Forward P/E
- 27.96
- Beta
- 1.15
- Short ratio
- 3.72
- Inst. own
- 102.21%
- Dividend
- 0.00
- Ex-div date
- Nov 25, 1996
- Earnings
- Nov 3, 2026
- 50-d avg
- 429.02
- 200-d avg
- 369.17
- 1y target
- 465.86
Key statistics
- Market cap
- 45.43B
- Enterprise value
- 52.10B
- Trailing P/E
- 117.15
- Forward P/E
- 27.96
- PEG ratio
- 1.79
- Price / sales
- 9.78
- Price / book
- 2.99
- EPS (TTM)
- 3.95
- Beta
- 1.15
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 3.59%
- Revenue (TTM)
- 4.64B
- Revenue growth
- 113.40%
- Free cash flow
- -142.07M
- Total cash
- 539.00M
- Total debt
- 5.48B
- Return on equity
- 1.92%
- Shares outstanding
- 98.19M
- Short % of float
- 3.25%
- 50-day average
- 429.02
- 200-day average
- 369.17
Analyst view
Consensus: buy
- Target (low)
- 349.00
- Target (mean)
- 465.86
- Target (high)
- 530.00
- Strong buy3
- Buy15
- Hold4
- Sell0
- Strong sell1
Next earnings
Nov 3, 2026
Expected Nov 3, 2026. Consensus EPS estimate 4.00.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2026 | Oct 4, 2026 | 4.00 | — | — | — |
| Aug 4, 2026 | Jul 4, 2026 | 3.01 | 3.05 | +0.04 | +1.33% |
| May 5, 2026 | Apr 4, 2026 | 2.31 | 2.70 | +0.39 | +16.88% |
| Feb 9, 2026 | Dec 31, 2025 | 4.51 | 4.53 | +0.02 | +0.44% |
| Nov 4, 2025 | Sep 27, 2025 | 3.21 | 3.40 | +0.19 | +5.92% |
| Aug 4, 2025 | Jun 28, 2025 | 2.94 | 2.95 | +0.01 | +0.34% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 13, 2026 | TD Cowen | main | Buy | Buy |
| Oct 7, 2026 | Barclays | main | Overweight | Overweight |
| Oct 1, 2026 | Guggenheim | main | Buy | Buy |
| Sep 21, 2026 | Goldman Sachs | main | Buy | Buy |
| Sep 9, 2026 | UBS | up | Neutral | Buy |
| Aug 27, 2026 | Piper Sandler | up | Neutral | Overweight |
About Waters Corporation
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Country
- United States
- Website
- waters.com
News
- Here’s How Much You Would Have Made Owning Waters Stock In The Last 20 Years
- Waters Gears Up to Report Q3 Results: How to Play the Stock?
- Waters Launches AI-Powered Peak Integration Expanding its Suite of Premium AI Subscription Capabilities for Empower Software
- Waters & Labcorp Expand Access to FDA-Approved HPV Screening Tests
- First Eagle U.S. Value Fund Q3 2026 Portfolio Review
- Waters And Labcorp To Expand Access To BD Onclarity HPV Assay
- Here’s How Much You Would Have Made Owning Waters Stock In The Last 20 Years
- TD Cowen Maintains Buy on Waters, Raises Price Target to $515
- Barclays Maintains Overweight on Waters, Raises Price Target to $500
- Nvidia, Micron and Other 5 S&P 500 Stocks With +100% Revenue Growth
Your note
Sign in to keep a note on WAT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BATRA UDIT | Chief Executive Officer | Stock Award(Grant) | Feb 24, 2026 | 36,557 |
| BENNETT JIANQING | Officer | Stock Award(Grant) | Feb 24, 2026 | 7,244 |
| CARPIO ROBERT L III | Officer | Stock Award(Grant) | Feb 24, 2026 | 3,615 |
| CHAUBAL AMOL | Chief Financial Officer | Stock Award(Grant) | Feb 24, 2026 | 8,505 |
| FEARON RICHARD H | Director | Purchase | Mar 5, 2026 | 3,302 |
| HUANG PEARL S. | Director | Stock Award(Grant) | Feb 24, 2026 | 3,276 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 8.64% | 8,484,939 | 3.93B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.53% | 6,415,552 | 2.97B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.83% | 4,740,524 | 2.19B | Jun 29, 2026 |
| Massachusetts Financial Services Co. | 4.71% | 4,625,035 | 2.14B | Jun 29, 2026 |
| State Street Corporation | 4.46% | 4,382,008 | 2.03B | Jun 29, 2026 |
| T. Rowe Price Investment Management, Inc. | 3.89% | 3,817,779 | 1.77B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 3,116,340 | 1.44B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 2,545,419 | 1.18B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.17% | 2,127,547 | 984.47M | Jun 29, 2026 |
| T. ROWE PRICE CAPITAL APPRECIATION Fd., INC.-T. Rowe Price Capital App | 2.14% | 2,101,625 | 972.47M | Jun 29, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 1,309,174 | 605.79M | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.30% | 1,274,542 | 589.76M | Aug 30, 2026 |